Canada must bridge the gap between world-class scientific discovery and commercial health innovation to build a robust, self-sustaining life sciences economy, experts said at Research Money's 25th annual conference in Ottawa. By prioritizing domestic procurement and aligning research funding with commercialization, Canada can transform its health care sector from a cost burden into a global engine for prosperity, they said.